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2Abstract 42 
43 
IgE is an ancient and conserved immunoglobulin isotype with potent immune function. 44 
Nevertheless, the regulation of IgE responses remains enigmatic and evidence for a role of 45 
IgE in host defense is limited. Herein we describe how topical exposure to a common 46 
environmental DNA-damaging xenobiotic initiates stress-surveillance by γδTCR+ 47 
intraepithelial lymphocytes resulting in IgE class-switching in B cells and accumulation of 48 
autoreactive IgE. High-throughput antibody sequencing revealed that γδ T cells shape the IgE 49 
repertoire by supporting specific VDJ rearrangements with unique CDRH3 characteristics. 50 
This endogenous IgE response, via the FcεRI, protects against epithelial carcinogenesis and 51 
FceR1a expression in human squamous cell carcinoma correlates inversely with poor disease 52 
outcome. Our data demonstrates a mutual role for T and B cell immune-surveillance in 53 
epithelial tissues and proposes IgE as a natural part of our host defense against epithelial 54 
damage and tumor development. 55 
56 
57 
58 
3Introduction 59 
60 
IgE is an ancient and highly conserved immunoglobulin isotype found in all mammals1. It is 61 
thought that IgE has evolved to provide protection against infection by macroparasites, such 62 
as helminths. However, although IgE is elevated in both mice and humans with helminth 63 
infections, IgE is not critical for protective immunity and much of the IgE raised is not 64 
parasite-specific2. An alternative hypothesis suggests that IgE may be important for immune 65 
responses against environmental toxins such as venoms3, and indeed, recent data indicates 66 
that IgE can protect against bee venom and limit snake venom toxicity4, 5, 6. Furthermore, 67 
aberrant IgE responses causing allergies are frequently directed at environmental irritants and 68 
non-replicating agents. A role for IgE in defending against immediate danger would be 69 
consistent with the very rapid mobilization of its effector functions. Therefore a broader 70 
paradigm has arisen, proposing that IgE represents an arm of early immune host-defense 71 
against xenobiotics or large parasites threatening tissue integrity7. However, what drives 72 
these responses in vivo, what IgE recognizes or whether they play a wider role in immune 73 
defense remain unknown. 74 
75 
IgE responses occur most frequently in epithelial tissues such as the skin, lung and gut, which 76 
contain resident IgE-binding cells. These barrier surfaces are continuously exposed to 77 
challenges from environmental xenobiotics and a prominent feature of their response to 78 
external insults is induction of type 2 immunity8 and IgE9, 10. In the murine skin epithelia, a 79 
resident γδTCR+ population of intraepithelial lymphocytes (IEL) controls tissue homeostasis 80 
via induction of IL-1311, a type 2 cytokine, and also promotes IgE upon challenge with 81 
protein allergens on stressed tissue12. These IELs can directly sense epithelial cell (EC) 82 
dysregulation via stress-sensing receptors, such as NKG2D, and this pathway plays a key role 83 
in promoting the IgE response12, 13. The capacity of IELs to detect EC-stress and initiate a 84 
restorative response has been termed lymphoid stress-surveillance (LSS) and plays an 85 
important role in early detection of stressed and pre-malignant cells13. Indeed, tissue-specific 86 
IELs regulate EC tissue integrity and are key to host-protection against carcinogenesis11, 13.  87 
88 
Many toxins and xenobiotics are also carcinogens. Hence, in defending against 89 
environmental xenobiotics, IgE may simultaneously confer protection against transformation 90 
and cancer in exposed tissues. Here we demonstrate the development of a potent and 91 
dominant IgE response following topical exposure to the common environmental xenobiotic 92 
and carcinogen, 7,12-Dimethylbenz[a]anthracene (DMBA). This endogenous IgE response is 93 
autoreactive and is indispensable for protection against cutaneous carcinogenesis. Further we 94 
demonstrate that tissue-resident γδTCR+ IELs play a unique role in initiating and regulating 95 
IgE production, driving an early, innate-like response, which directs a subsequent adaptive 96 
response supported by IL-4-producing CD4+ αβ T cells. By deep-sequencing IgE and IgG1 97 
from germinal center (GC) B cells and plasma cells (PCs), we show that γδTCR+ IELs shape 98 
a distinct IgE repertoire that is dependent on the presence of EC DNA-damage. Thus, LSS 99 
promotes a unique IgE response, which is part of an early host defense mechanism providing 100 
protection against cancer.     101 
102 
103 
4Results 104 
105 
Carcinogen-induced EC-damage triggers rapid local and systemic IgE responses 106 
DNA-damaging xenobiotics such as DMBA are commonly found in the environment and 107 
have been implicated in carcinogenesis14, 15. We found that a single topical application of 108 
DMBA to WT mice induced a rapid IgE response in serum (Fig. 1a). DMBA exposure was 109 
associated with early EC stress, as shown by upregulation of the NKG2D-ligand Rae-1 110 
(Supplementary Fig. 1a), and significant DNA-damage. The number of ECs containing 111 
double-stranded (ds) DNA-breaks, assessed by staining for the phosphorylated histone H2A 112 
variant H2AX (γH2AX), peaked between 3-7 days after exposure (Supplementary Fig. 113 
1b,c). To cause substantial DNA-damage, epidermal Langerhans Cells (LCs) must 114 
metabolize DMBA to the more mutagenic compound DMBA-trans-3,4-dihydrodiol. LC-115 
deficient mice displayed  less EC DNA-damage following a single dose of DMBA16 116 
(Supplementary Fig. 1d) and also failed to show increased serum IgE (Fig. 1b). The defect 117 
was specific to this experimental protocol, as LC-deficient mice generated IgE to other 118 
topical challenges12 and, if exposed to DMBA repeatedly, they developed both DNA-damage 119 
and IgE responses (Supplementary Fig. 1d,e). Other DNA-damaging skin challenges such 120 
as UV-irradiation also induced IgE (Supplementary Fig 1f,g). Once weekly exposure to 121 
DMBA led to development of papillomas and squamous cell carcinomas (SCCs) after 8-15 122 
weeks. This was associated with high levels of IgE, which rose progressively as EC DNA-123 
damage accumulated (Fig. 1c). Indeed, even if DMBA was only given for 5 days and then 124 
stopped, mice developed skin tumors and serum IgE continued to rise (Supplementary Fig. 125 
1h). The systemic IgE responses were paralleled by infiltration and accumulation of IgE in 126 
the acutely damaged skin (Fig. 1d) and in the skin tumors (Fig. 1d,e), which was mainly 127 
carried by FcεRI-expressing basophils (Fig. 1d). The tumor IgE was partly due to local IgE 128 
production as mature IgE transcripts were more expressed in the tumor tissue than the 129 
surrounding skin, whereas IgG1 and IgM transcripts were lower in the tumors (Fig. 1f). 130 
Together this data demonstrates that the EC-damage triggered by DMBA exposure potently 131 
promotes IgE which accumulates in the resulting skin tumors.   132 
133 
Topical carcinogen exposure induces local B cell class-switching resulting in a dominant 134 
IgE response in the draining LN 135 
To investigate the origin of the DMBA-induced IgE response, we examined B cells in the 136 
skin-draining LNs during acute DMBA exposure (pre-malignancy). Two applications of 137 
DMBA on the ear skin induced enlarged skin-draining LNs with formation of GCs and class-138 
switching of GC B cells (Fig. 2a) as well as increased numbers of CD138+ PCs, which had 139 
class-switched primarily to IgE and IgG1, with little or no induction of IgG2a (Fig. 2b). This 140 
predominant type 2 response was localized to the skin-draining LNs, as there was no 141 
induction of GCs or class-switched PCs in the spleen (data not shown). Similar findings were 142 
seen upon repeated weekly exposures to DMBA on back skin. However, under these 143 
conditions, the GC structures and the PC IgG1 responses diminished with time, resulting in a 144 
dominant IgE response with nearly 80% of all PCs in the LNs switched to IgE by week 5 145 
(Fig. 2c). Thus, carcinogen-induced EC-damage promotes a local type 2 B cell response with 146 
prevailing IgE production.  147 
148 
IgE induced by EC-damage protects against carcinogenesis 149 
To explore whether the IgE response induced by carcinogen(s) is important for host defense, 150 
we assessed skin tumor formation in mice lacking IgE (Igh7-/-). Following DMBA exposure 151 
Igh7-/- mice developed tumors sooner and more rapidly than their WT counterparts. They also 152 
developed significantly more and larger tumors (Fig. 3a). Of note, the IgG1 response in IgE-153 
5deficient mice was identical to DMBA-treated WT mice (Supplementary Fig. 2a) and the 154 
number of IgE-effector cells in the tissue was normal (Supplementary Figure 3a). The 155 
protective effect of IgE was mediated by signaling through its high affinity receptor, FcεRI, 156 
as mice lacking this receptor (FceR1a-/-) had an enhanced susceptibility to DMBA 157 
carcinogenesis, despite having normal IgE and IgG1 levels (Fig 3b and Supplementary Fig 158 
2b). The effect of FcεRI-signaling was most likely mediated by basophils, as this was the 159 
main IgE-carrying cell population in the tumors (Fig. 1d). Moreover, Cpa3Cre/+ mice, lacking 160 
skin mast cells, were not more susceptible to tumor development, suggesting that FcεRI-161 
signaling in basophils is sufficient to protect against carcinogenesis (Supplementary Fig. 162 
3b). Splenic basophils from Igh7-/- mice were functionally equivalent to WT, however the 163 
skin tumour microenvironment was significantly altered in the absence of IgE 164 
(Supplementary Fig. 3c-e).  165 
To test whether similar tumor-related IgE responses occur in humans, we analyzed 12 newly 166 
incised skin SSC samples. IgE-bearing cells were found in all tumor and peri-lesional skin 167 
samples, varying in frequency from around 1% to over 40% of CD45+ tumor infiltrating 168 
leukocytes (Fig. 3c). The FcεRI+ cells were mainly found in the peritumoral infiltrate at the 169 
interface between the stroma and the neoplastic keratinocytes with some entering the tumor 170 
and/or hair follicle (averaging 11.7±2.9 cells per mm2) (Supplementary Fig. 4). IgE-bearing 171 
cells accumulated more in the skin compared to matched blood samples, however, tumor 172 
tissue contained fewer cells than histopathologically normal looking peri-lesional skin (Fig. 173 
3c). In an additional cohort of SCC patients, gene-expression analysis revealed that FceR1a 174 
was higher in unaffected skin areas and lower in developed tumors, with the lowest level 175 
detected in high-risk and metastatic SCCs. A significant linear trend was observed between 176 
FceR1a expression and risk of more advanced SSC (Fig. 3d). Together this data indicates 177 
that IgE, via FcεRI, protects against carcinogen-induced SCC and that expression of FcεRI 178 
on leukocytes in human SSC correlates inversely with risk of more severe disease. 179 
180 
Humoral immunity induced by EC-damage depends on αβ T cell-derived IL-4 181 
Both conventional and non-conventional modes of inducing class-switching to IgE exist8. 182 
Thus, we first explored whether induction of tumor-protective IgE was αβ T cell-dependent. 183 
Mice lacking αβ T cells (Tcrb-/-) had no enlargement of skin-draining LNs, no GCs, and no 184 
IgG1 or IgE PCs following topical DMBA (Fig. 4a). The response was also dependent on a 185 
normal TCR repertoire, as it could be restored in Tcrb-/- mice by transferring polyclonal CD4+ 186 
T cells, but not TCR-restricted transgenic OTII CD4+ T cells (Supplementary Fig. 5a). 187 
Furthermore, blocking CD40L partially inhibited LN activation and repressed GC formation 188 
and generation of IgE and IgG1 PCs in WT mice (Supplementary Fig. 5b). Similar defects 189 
in type 2 class-switched PCs were seen in interleukin 4-deficient (IL4-/-) mice, although these 190 
mice did show enlargement of LNs comparable to WT and had some small GCs (Fig. 4a). 191 
IL4-/- mice displayed some class-switching to IgG2a, which was never observed in WT or in 192 
Tcrb-/- (data not shown). Bone marrow (BM) chimera experiments showed that the source of 193 
IL-4 was haemapoeitic cells and not irradiation-resistant skin-resident cells (Supplementary 194 
Fig. 5c). To test whether the αβ T cell requirement reflected the need for IL-4, we 195 
reconstituted Tcrb-/- mice with IL-4-sufficient or deficient CD4+ T cells prior to DMBA 196 
exposure. Only IL-4-sufficient CD4+ αβ T cells were able to rescue the humoral response and 197 
IgG1/IgE production (Fig. 4b). IL-4 was not only essential for the IgE response, but also 198 
required for tumor protection in the DMBA-carcinogenesis model, as IL4-/- mice showed 199 
significantly earlier onset of disease, higher incidence of tumors and larger tumors compared 200 
to WT controls (Fig. 4c). Moreover, tumor-bearing IL4-/- mice did not produce IgE and had 201 
6diminished IgG1 levels, but higher IgG2a levels (Supplementary Fig. 2c). Thus, αβ T cell-202 
derived IL-4 is critical for IgE production and tumor protection following DMBA exposure.  203 
204 
Induction of tumor-protective IgE requires γδ TCR+ IEL 205 
We have shown previously that skin γδTCR+ IELs are key for protective immunity against 206 
chemical carcinogenesis and are strong inducers of local type 2 immune responses11, 12, 13. 207 
Therefore, we assessed mice lacking γδ T cells (Tcrd-/-) and found that they had less LN 208 
hypertrophy following DMBA exposure, but normal numbers of GC B cells. They developed 209 
comparable IgG1 PCs, but had significantly impaired IgE PC responses (6510±768 in Tcrd-/- 210 
vs 16758±1958 in WT at day 7) (Fig. 5a). This abnormality was already present at day 4, 211 
when numbers of IgE PCs and serum IgE levels were increased in WT mice, but remained 212 
undetectable in Tcrd-/- mice (Fig. 5a,b). At day 4, GCs were not yet enlarged, suggesting that 213 
the early γδ T cell-dependent IgE response may be of extra-follicular origin. To explore this, 214 
we utilized mice with a B cell-specific defect in the transcription factor Bcl6 215 
(CD19creBcl6fl/fl). CD19creBcl6fl/fl mice did not develop a GC response following topical 216 
DMBA, despite normal LN enlargement, however, they showed equivalent numbers of IgE+ 217 
and IgG1+ PCs to littermate heterozygous controls and WT animals (Supplementary Fig. 218 
5d). We next asked whether the γδ T cells involved in the response were located in the skin 219 
itself or in a secondary lymphoid organ such as the draining-LNs. To do this we exploited 220 
that skin resident γδTCR+ IELs are radiation-resistant11 and created Tcrd-/-→WT and 221 
WT→Tcrd-/- BM chimeras in which γδ T cells were restricted to the skin or LNs respectively 222 
(Fig. 5c). Under these conditions, IgE was significantly reduced only when γδTCR+ IELs 223 
were missing from the skin (despite being present in the LNs) (Fig. 5d). The IgG1 response 224 
was induced to WT level regardless of γδ T cell distribution (Fig. 5d). The relevant IgE-225 
promoting γδ subset in the skin were the Vγ5+ IELs as the Vγ4+ and other ‘non-Vγ5+’ γδ T 226 
cells were reconstituted to WT levels and mice lacking only the canonical Vγ5Vδ1+ IELs also 227 
had diminished IgE responses (Fig. 5c,e). This demonstrates that the tumor-protective IgE, 228 
induced by EC-damage, uniquely depends on γδTCR+ IEL in the tissue.  229 
230 
γδ T cells promote a distinct IgE repertoire in response to carcinogen-induced EC-231 
damage 232 
To understand the nature of the humoral response produced during EC-damage, and the role 233 
of γδ T cell immune-surveillance, we sorted GC B cells and PCs from skin draining-LNs of 234 
WT and Tcrd-/- mice following topical DMBA. Analysis of the IgG1 and IgE heavy-chain 235 
repertoires using high-throughput sequencing revealed that IgE-producing clones accounted 236 
for the largest component of the clonal expansion in WT mice (Supplementary Fig. 6a). As 237 
expected, average clone sizes for IgG1 were greater amongst PCs than GC B cells. In 238 
contrast, IgE clones among PCs and GC B cells were equivalent and were larger than IgG1 239 
clones (Fig. 6a). Furthermore, Tcrd-/- mice showed defective IgE clone expansion in GC B 240 
cells, while IgG1 development was unaffected (Fig. 6b). Use of the Alakazam tool17 showed 241 
that the PC IgE repertoire was significantly less diverse in Tcrd-/- compared with WT mice in 242 
all but the most common clones (Fig. 6c). Thus, absence of some PC clones in Tcrd-/- mice 243 
may explain that fewer IgE+ PCs developed in these mice (Fig. 5), despite similar average 244 
clone size (Fig. 6b). In contrast, the IgG1 repertoire diversity of Tcrd-/- mice appeared normal 245 
(Fig. 6c).   246 
247 
We also analyzed the physicochemical properties of the CDRH3 regions using principal 248 
component analysis (PCA) of Kidera factors18. The data demonstrated clear differences in 249 
CDRH3 protein structure between switched GC B cells and PCs as well as IgG1- and IgE-250 
7switched clones in WT mice (Fig. 6d), indicating that the majority of PC IgE clones were of 251 
extra-follicular origin and had switched directly from IgM to IgE. This was supported by 252 
clonal analysis showing that <30% of IgE clones were shared with IgG1 and only around 253 
30% of IgE PC clones were shared with GC IgE clones (Supplementary Fig. 6b,c). 254 
Furthermore, Kidera PCA showed that IgE/IgG1 in Tcrd-/- mice were very different to WT, 255 
demonstrating that immune-surveillance by γδ T cells play a role in selecting the 256 
physiochemical properties of the CDRH3 regions (Fig. 6d). 257 
Selection events are also expected to shape the B cell repertoire in terms of V, D, J gene-258 
usage. We found that only 5 major IgHV and 5 IgHD family genes were commonly used, but 259 
all 4 IGHJ genes were used for both IgG1 and IgE (Supplementary Fig. 6d-f). The third 260 
most frequent D gene could not be annotated by IMGT, most likely due to an IGHD gene in 261 
the FVB genome that is absent from the IMGT genomic data, as the heavy chain repertoire is 262 
highly variable between inbred strains19. We annotated this new gene Dx. 3D analysis of VDJ 263 
usage in PC IgE demonstrated that V1D2 was the dominant selection, consistent with data 264 
showing the IgHV1 family being most frequently used in mouse Ig19, 20. J usage was 265 
approximately equal between the 4 family groups (Fig. 6e). This analysis also revealed that 266 
particular VDJ combinations were almost absent in PCs from mice lacking γδ T cells (Fig. 267 
6e) with the missing clones predominately using the novel V3Dx segment (Fig. 6e-g).  268 
To further analyze the V3Dx clones, we compared their CDRH3 physicochemical properties 269 
with those of clones using the same V but a different D family gene (V3D2), with the most 270 
common clones (V1D2) or with a combination not requiring γδ T cell selection (V14D2). 271 
Kidera factor PCA, demonstrated that the V3Dx clones had unique CDRH3 physicochemical 272 
characteristics (Fig. 6h) and contained a lower frequency of aromatic and small amino acids, 273 
but a higher frequency of aliphatic and basic amino acids, as well as a higher isoelectric point 274 
(Fig. 6i). These characteristics suggest the antigen-binding site to be hydrophobic with the 275 
loop having a slight positive charge at blood pH. In addition, the V3Dx-expressing clones 276 
had shorter CDRH3 regions, indicating antigen selection21, 22, and were more germline in 277 
nature carrying fewer mutations (Fig. 6j). In sum, this data indicates that in response to 278 
carcinogen-induced EC-damage γδTCR+ T cells shape the IgE repertoire by supporting 279 
specific VDJ rearrangements, resulting in unique CDRH3 antigen-binding site characteristics 280 
with properties suggesting polyreactive autologous binding. 281 
282 
IgE induced by EC DNA-damage is autoantigenic and the repertoire differs from 283 
inflammation-induced IgE 284 
As the IgE responses induced by topical DMBA had unique characteristics and were 285 
triggered by EC-damage, we explored whether they were auto-reactive in nature. We 286 
screened their binding properties using the human Hep2 cell line and observed unique 287 
patterns of staining, demonstrating both autoreactivity and cross-species reactivity in WT 288 
mice (Fig. 7a and Supplementary Fig. 7a). The most common staining patterns were i) 289 
‘nuclear dots’ indicating anti-nuclear specificity and ii) ‘cytoplasmic vesicles’ resembling 290 
stress granules. This staining was never detected with IgG1 from the same WT mice. In 291 
addition, IgE reactivity towards ds-DNA (Fig. 7b) and towards acutely damaged ECs, 292 
frequently around hair-follicles, in DMBA-treated epidermal sheets (Supplementary Fig. 7f) 293 
was detected. In contrast, no autoreactivity was found using IgE from DMBA-treated Tcrd-/- 294 
mice or IgE from WT mice treated topically with 12-O-Tetradecanoylphorbol-13-acetate 295 
(TPA) (Fig. 7a and Supplementary Fig. 7b,c), which does not provoke EC DNA-damage 296 
(Fig. 7c), but triggers skin inflammation, EC-stress and raises IgE levels. 297 
We next compared the PC IgE repertoire triggered by EC-damage following DMBA to PC 298 
IgE induced by topical exposure to TPA. Alakazam analysis showed clear differences 299 
between the IgE repertoires induced by these chemicals, with TPA-induced IgE-producing 300 
8PCs exhibiting significantly less diversity throughout the repertoire (Fig. 7d). Kidera factors 301 
PCA demonstrated more heterogeneity in the CDRH3 regions of inflammation-induced IgE 302 
compared with EC-damage-induced IgE and there was little overlap between the two 303 
responses (Fig. 7e). In parallel, VDJ gene family-usage amongst inflammation-induced IgE 304 
was dominated by V1 genes, with significantly less selection for V3 and V14 genes 305 
compared with EC-damage-induced IgE (Fig. 7f,g). Notably, inflammation also did not 306 
generate the V3Dx-expressing clones, which we had found to be promoted by γδ T cells in 307 
response to EC DNA-damage (Fig. 7g). Together these results indicate, that EC DNA-308 
damage in the skin drives a unique, autoreactive IgE repertoire that is distinct from that 309 
induced in response to a local acute inflammatory stimulus.  310 
311 
Discussion 312 
313 
Here we directly tested whether IgE can be induced by exposure to environmental 314 
xenobiotics and if this has consequences for host immunity. We found that IgE is rapidly and 315 
potently induced by cutaneous exposure to the carcinogen DMBA and accumulates in the 316 
skin and tumors on FcεRI-expressing effector cells. The IgE response is initiated and shaped 317 
by γδTCR+ IELs and is protective against epithelial carcinogenesis. FcεRI-expressing cells 318 
also accumulate in human skin SCCs and the level of expression correlates with disease 319 
severity. Together, our data suggest IgE is an active part of early tissue immune-surveillance 320 
against detrimental environmental xenobiotics/toxins and defends against EC tumor 321 
development.  322 
323 
Xenobiotics are ubiquitous in the environment and polyaromatic hydrocarbons (PAHs), such 324 
as DMBA, arise from many sources including industrial combustion exhaust, car emissions, 325 
tobacco smoke and heated cooking oil14, 15. PAHs are the main organic constituent of 326 
particulate matter in air pollution, and their levels correlate with the prevalence and severity 327 
of atopic dermatitis (AD) in man23, 24. Chronic skin exposure to air pollutants have been 328 
shown to induce AD-like features and increased IgE production in mice. Of note, the AD-like 329 
gene expression was dependent on direct ligation of the aromatic hydrocarbon receptor 330 
(AhR) on EC by PAH, but the increase in IgE was not25. Consistent with this, we found that 331 
initiation of IgE after topical DMBA depends on DNA-damage in EC, and thus appears not 332 
to be a direct effect of AhR engagement (Fig. 1b). Previous work has shown that host DNA 333 
can selectively promote IgE responses, suggesting that dying host cells have unique IgE 334 
adjuvant activity26. Furthermore, expression of autologous stress-antigens, such as NKG2D-335 
ligands, on dysregulated skin EC promotes IgE production12. Topical TPA also induces 336 
NKG2D-ligand expression on EC27, which may partly support IgE induction by this 337 
inflammatory agent (Fig. 7). However, our sequencing analysis revealed that different types 338 
of tissue-dysregulation initiate distinct IgE repertoires (Fig. 7d-g). In humans, self-reactive 339 
IgE has been associated with several autoimmune diseases, including systemic lupus 340 
erythematous28, 29 and bullous pemphigoid30 as well as with AD31 and IgE is also markedly 341 
raised in patients with primary immune deficiencies32. Together, the data suggests that IgE 342 
responses are potently induced by autologous cell stress/damage, which is readily induced in 343 
skin EC by exposure to environmental toxins and xenobiotics. 344 
345 
IELs are constitutively resident in epithelial tissues providing a ‘first line of defense’. A large 346 
proportion of IELs carry γδTCRs and are autoreactive in nature. Although only few γδTCR 347 
specificities have been defined to date, the majority seem to be self-antigens, suggesting a 348 
paradigm in which IELs display receptors specific for common stress-molecules in particular 349 
tissues33. Skin IELs express a Vγ5Vδ1TCR, as well as high levels of NKG2D and xenobiotic-350 
9activated receptors and are thus poised to recognize EC dysregulation. We show here that 351 
these ΙELs are key to induction and regulation of the IgE response following topical DMBA 352 
(Fig. 5). They elicit IgE in parafollicular regions very early in the response and subsequently 353 
trigger a conventional adaptive response that requires polyclonal αβTCR+ CD4+ T cells in 354 
draining-LNs to produce IL-4 and engage CD40 (Fig. 4, 5 and Supplementary Fig. 5). This 355 
mode of IgE induction thus differs from regulation of self-reactive ‘natural IgE’, which is 356 
also γδ T cell-driven, but is independent of αβ T cells and MHCII34, 35. Deep-sequencing also 357 
demonstrated that γδ T cells shaped the repertoire and the nature of the antibodies produced 358 
in response to EC DNA-damage. In the absence of stress-sensing γδ T cells, certain 359 
autoreactive B cell clones were not selected and the physicochemical properties of the IgE 360 
were altered (Fig. 6, 7). Thus, antibody deep-sequencing revealed a previously unrecognized 361 
mode of B cell selection dictated by immune-surveilling tissue-resident IELs. 362 
363 
It has long been proposed that γδ T cells are key players in host defense against cancer, and 364 
we have previously shown a non-redundant role for tissue-specific γδIELs in protection 365 
against skin carcinogenesis11, 13, 27. These effects are usually considered to reflect innate 366 
properties of γδ T cells such as cytotoxicity and cytokine production, but here we extend 367 
these findings showing that initiation of autoreactive IgE by γδ T cells protects against 368 
xenobiotic-induced skin cancer. Thus a ‘second line of host defense’ is provided via adaptive 369 
B cell responses and FcεRI-expressing effector cells (Fig. 3a,b). To our knowledge, this is 370 
the first demonstration that endogenous IgE can suppress spontaneous tumor growth. Our 371 
findings are supported by evidence that both passive and active immunization with tumor 372 
antigen-specific IgE can eradicate tumors in vivo, and antibody engineering has revealed such 373 
IgE to be safe and more effective than IgG136, 37. How IgE inhibits tumor growth remains to 374 
be determined, but in our experiments it required FcεRI expression and mast cells were not 375 
essential, therefore it may involve soluble factors and/or cytotoxicity mediated by basophils. 376 
377 
In humans, ~85% of all cancers arise in epithelial tissues and EC skin cancers are strongly on 378 
the rise with considerable associated morbidity and mortality38, 39. UV-irradiation is a well-379 
known DNA-damaging agent, but epidemiological studies indicate that environmental 380 
chemical carcinogens can lead to skin SCC development, as was recognized in 1775 when a 381 
causal link between scrotal SCC and soot exposure (containing PAHs) in chimney sweeps 382 
was reported40. Moreover, recent studies show that tobacco smokers are exposed to high 383 
levels of polyaromatic benz[a]antracene and their likelihood of developing skin SCC is 384 
increased by more than 50%41. There are few comprehensive studies on IgE and cancer risk 385 
in humans, but both a meta-analysis and a prospective cohort study show a significant, albeit 386 
weak, negative correlation between serum IgE and overall cancer risk42. In addition, a recent 387 
study found that FceR1a was among the top 50 genes associated with positive survival in 39 388 
human malignancies. The same work showed that of all leukocyte populations, the presence 389 
of intratumoral γδ T cells was the most significant prognostic indicator of favorable cancer 390 
survival. A high number of infiltrating PCs was also strongly associated with good clinical 391 
outcome43. Consistent with these observations, we found that FcεRI-expressing (and IgE-392 
bearing) cells were abundant in human SCCs and there was an inverse correlation between 393 
levels of FceR1a in the tissue and more advanced disease (Fig. 3c,d). Of note, the use of 394 
omalizumab (blocking IgE mAb) has been associated with more frequent development of 395 
cancer, particularly epithelial and solid organ cancers44. Together these findings suggest that 396 
in man the IgE-FcεRI axis is part of a tumor-protective immune response. 397 
398 
10
In summary, herein we show that skin exposure to a common environmental xenobiotic 399 
induces potent humoral immunity dominated by IgE. The IgE is autoreactive in nature, 400 
induced by EC-damage and regulated by tissue-resident γδ T cells. IgE represent a unique 401 
humoral component of the rapid lymphoid stress-surveillance response to epithelial (DNA) 402 
damage and, in parallel with tissue γδIELs, protects against carcinogenesis. Our data provides 403 
experimental support for the ‘toxin hypothesis’, proposing IgE as a host defense mechanism 404 
against non-infectious cell-damaging environmental xenobiotics, that can provoke tumor 405 
development. These effects of IgE and γδ T cells, both of which are highly tissue tropic, are 406 
likely to be most prominent in epithelial tissues. Indeed, epidemiological studies suggest a 407 
particularly strong inverse association between allergic disease and cancer in tissues that 408 
interface with the external environment such as skin, mouth, throat, colon and cervix45. 409 
410 
411 
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Methods 412 
413 
Mice  414 
Genetically altered mice were generated as previously described. Tcrd-/-46, Tcrb-/-47, IL4-/-48, 415 
Langerin-DTA49 (LC-deficient) and Vg5Vd1-/-50,51 were on the FVB/N background after > 10 416 
backcrosses; Igh-7-/-52, FceR1a-/-53 and Cpa3Cre/+54 were on the BALB/c background after >10 417 
backcrosses; and OTII Tg55, Tcrb-/-56, CD19-Cre57 and Bcl6fl/fl58 were on the C57BL/6 418 
background. Strain-matched WT control animals were purchased from Charles River. Mice 419 
were bred and maintained in individually ventilated cages under specific pathogen-free 420 
conditions. Age-matched, female mice were used for all experiments at ≥ 7 weeks of age and 421 
selected at random from a large pool when allocated to experiments. All studies were 422 
approved by Imperial College AWERB (Animal Welfare and Ethical Review Body) and by 423 
the UK Home Office. Experiments involving cancer studies strictly adhered to the guidelines 424 
set out by the National Cancer Research Institute (NCRI) and Workman et al. in ‘Guidelines 425 
for the Welfare and Use of Animals in Cancer Research’59. All studies using animals were 426 
conducted following the Animal Research: Reporting In Vivo Experiments (ARRIVE) 427 
guidelines60.  428 
429 
Chemical cutaneous damage and carcinogenesis  430 
Chemicals 7,12-Dimethylbenz[a]anthracene (DMBA) and 12-0-tetradecanoylphorbol-13-431 
acetate (TPA) were purchased from Sigma and dissolved in acetone and 100% ethanol 432 
respectively. Acute damage was induced by exposing the dorsal sides of the ear skin to a 433 
single or repeated 200nM dose of DMBA or 2.5nM dose of TPA, in 25μl. 434 
For cutaneous carcinogenesis age-matched female mice were used at 7 weeks of age. The 435 
dorsal back area was shaved with a surgical blade and mice rested for 1 week. Applications 436 
of chemicals and tumor monitoring were performed as previously described13. In brief, 437 
200nM DMBA was carefully and slowly applied by pipette, in a 100μl volume, to the entire 438 
shaved skin area. Mice were rested for one week and 100nM DMBA then applied weekly. 439 
Hair regrowth during the experiment was gently removed by clipping with trimmers. Mice 440 
were monitored daily and cutaneous tumors were counted and measured with a caliper once 441 
weekly. Back skin and tumors were evaluated by visual inspection by an observer blinded to 442 
the experimental groups.  443 
444 
UV-irradiation 445 
The back skin of FVB mice was shaved using electrical clippers 3 days before UV-446 
irradiation. Mice were exposed to the UV light source in their cages placed under four 100 W 447 
UV lamps with the spectral output 270-350 nm (predominantly UVB) (Philips TL12 lamps). 448 
The total dose of UVB radiation was monitored during each exposure using an IL-400 A 449 
UVB photometer (International Light). Mice were given 100mJ/cm2 three times a week.  450 
451 
Tissue Processing 452 
Tissue was cut into small 1mm2 pieces using a scalpel blade and incubated for 2 hrs in 453 
digestion buffer containing 25ug/ml Liberase (Roche), 250ug/ml DNAseI (Roche) and 1x 454 
DNAse buffer (1.21 Tris base, 0.5g MgCl2 and 0.073g CaCl2) at 37°. Following digestion, 455 
tissue was transferred into C-tubes (Miltenyi Biotech) containing RPMI-1640 media (Thermo 456 
Fisher) supplemented with 10% heat-inactivated foetal calf serum, 1% Penicillin-457 
Streptomycin-Glutamine (Thermo Fisher) and physically disrupted using a Miltenyi cell 458 
dissociator. Cell suspensions were then filtered and cells counted using a CASY cell counter 459 
(Roche).  460 
461 
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Flow cytometry 462 
Cell suspensions were blocked for non-specific binding using antibody against FcγR (2.4G2) 463 
and 2% normal rat serum (Sigma) prior to any staining protocols. For staining of cell surface 464 
markers, cell suspensions were stained with fluorochrome-conjugated antibodies or 465 
appropriate isotype control with the addition of a fixable, live/dead discrimination dye 466 
(Invitrogen) for 25 min and subsequently washed. Intracellular staining was then carried out 467 
using an Intracellular Staining kit as per manufacturer’s instruction (ThermoFisher 468 
Scientific). Cells were fixed for 10 min at 4°C, washed with Perm buffer and stained for 469 
intracellular markers for 25 min. For intranuclear γH2AX staining, cells were 470 
fixed/permeablized in ice-cold 70% ethanol at -20°C for 2 hrs, blocked with 2% normal 471 
mouse serum (Sigma), Fc-block and 2% fetal calf serum for 15 min, followed by 45 min 472 
staining for γH2AX at room temperature. Stained cells were analyzed using BD FACSVerse 473 
and Fortessa X20 (BD Biosciences, NJ, USA) machines. Data analysis was performed using 474 
FlowJo 10 for Mac (TreeStar, OR, USA). 475 
Antibodies were sourced from eBioscience unless otherwise stated. The following antibodies 476 
were used: anti-CD45 (30-F11), anti-B220 (RA3-6B2), anti-CD38 (90/CD38, BD), anti-477 
CD138 (281-2, BD), anti-CD95 (Jo2), anti-GL7 (GL-7), anti-CD3 (145-2C11, Biolegend), 478 
anti-IgE (23G3), anti-IgG1 (M1-14D12), anti-IgG2a (R19-15, BD), anti-TCRβ (H57-597), 479 
anti-TCRγδ (eBioGL3), anti-Vγ5 (536), anti-Vγ4 (UC3-10Ab, Biolegend), anti-CD117 480 
(2B8), anti-CD41 (MWReg30, Biolegend), anti-FcεRI (MAR-1, Biolegend), anti-IL-4 481 
(11B11), anti-IL-6 (MP5-20F3, Biolegend), anti-CD63 (NVG-2, Biolegend) and γH2AX 482 
(JBW301, Millipore). 483 
484 
ELISA 485 
For IgG1 and IgG2a antibodies, NUNC Immune Maxisorp 96-well plates (Thermo Scientific) 486 
were coated with 5 μg/ml goat anti-mouse IgH+L (Southern Biotech) in borate buffered 487 
saline at 37°C for 3hr. After washing, plates were blocked with PBS containing 0.5% BSA 488 
for 1 hr at room temperature, and appropriately diluted sera added and incubated overnight at 489 
4°C. After washing, plates were incubated with alkaline phosphatase-conjugated polyclonal 490 
goat anti-mouse IgG1 or IgG2a (also detects IgG2c in C57BL/6 mice) (both Southern 491 
Biotech) for 5 hr at 4°C. Following further washing, the alkaline phosphatase substrate pNPP 492 
(Sigma) was added and absorbance measured at 405 nm. Total IgE was measured by an IgE 493 
capture method. Sera to be tested and IgE standard were added to plate wells coated with 1 494 
μg/ml rat monoclonal anti-mouse IgE (PharMingen) and blocked with 1% rat serum. 495 
Biotinylated rat monoclonal anti-mouse IgE (PharMingen) at 1 μg/ml were then added and 496 
incubated for 2h at 37°C. After washing in PBS 0.05% Tween, plates were incubated 497 
with alkaline phosphatase-conjugated Streptavidin (PharMingen) for 1 hr at 37°C. After 498 
washing, detection of antibody levels was carried out by addition of alkaline phosphatase 499 
substrate pNPP (Sigma) and absorbance measured at 405 nm.  500 
For IgE ds-DNA autoreactivity, MaxiSorp plates were coated with 1 μg/ml rat monoclonal 501 
anti-mouse IgE (PharMingen) and blocked with 1% rat serum and 3% milk. Serum samples 502 
were screened at 1:25 dilution. 100 ng/ml biotinylated herring sperm ds-DNA (Promega) was 503 
then added and incubated overnight at 4°C. After washing in PBS 0.05% Tween, plates were 504 
incubated with alkaline phosphatase-conjugated Streptavidin (PharMingen) for 1 hr at 37°C. 505 
After washing, detection was carried out by addition of alkaline phosphatase substrate pNPP 506 
(Sigma) and absorbance measured at 405 nm. Autoantibody levels were expressed in 507 
arbitrary ELISA units. 508 
509 
HEp-2 staining 510 
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Auto-reactivity of IgE was tested by indirect immunofluorescence using HEp-2 cells. Serum 511 
samples were diluted appropriately (tested in dilutions between neat – 1:25, depending on 512 
IgE titers) and incubated on HEp-2 slides (Bio-Rad) overnight at 4°C. After washing in PBS, 513 
slides were incubated with purified rat anti-mouse IgE (BD) for 2hrs, washed again and 514 
further incubated with anti-rat 555 secondary antibody (ThermoFisher) for 1hr at room 515 
temperature. As controls, serum from similarly treated IgE-deficient mice was also assessed 516 
as well as naïve WT serum. Slides were thoroughly washed and mounted with Vectashield 517 
containing DAPI (Vectashield) and visualised with a Leica DM4 fluorescence microscope 518 
(Leica). 519 
520 
Immunofluorescent staining of tumor samples 521 
Tumors were removed from the back along with a small piece of adjacent skin and snap 522 
frozen in OCT on dry ice. 6 μm sections were cut using a Leica JUNG CM1800 cryostat and 523 
stored at -80ºC. For staining, slides were returned to room temperature before fixation with 524 
4% paraformaldhyde for 15min. Samples were then blocked in 5% goat serum for 1 hr at 525 
room temperature before staining with rat anti-mouse IgE (BD) overnight at 4°C. Following 526 
staining, samples were washed and incubated with alexa-fluor 555 conjugated, goat anti-rat 527 
IgE (ThermoFisher). After extensive washing, samples were mounted in VectaShield 528 
containing DAPI (Vectashield) and visualised with a Leica SP5 confocal laser-scanning 529 
microscope (Leica). 530 
531 
Epidermal sheets 532 
Ears were collected, split into dorsal and ventral sides and floated dermis side-down in 0.5 M 533 
NH4SCN for 40 minutes, 37°C, 5% v/v CO2. Subsequently, intact epidermal sheets were 534 
isolated and washed in PBS. They were then fixed in ice-cold acetone at -20°C for 15 535 
minutes, followed by rehydration in PBS. Non-specific binding to the epidermal tissue was 536 
blocked with 2% BSA for 1 hr and then 1:25 dilution of test sera was added and incubated 537 
overnight at 4°C. Any IgE binding to the tissue was visualized by first incubating with rat 538 
anti-mouse IgE (BD) followed by alexa-fluor 555 conjugated, goat anti-rat IgE both for 1 hr 539 
at room temperature. After extensive washing in PBS, samples were mounted in VectaShield 540 
containing DAPI (Vectashield) and visualised with a Leica SP5 confocal laser-scanning 541 
microscope (Leica). 542 
543 
Adoptive Transfer experiments 544 
Whole CD4+ T cells were isolated from the spleens of donor WT and IL4-/- mice (using 545 
Miltenyi MACS isolation kits). For OTII transfer experiments, OTII Tg CD4+ T cells were 546 
cell sorted using OVA-peptide loaded tetramers (NIH, tetramer facility). 2x106 cells were 547 
intravenously injected, mice were rested for 24 hr and the dorsal ear skin then exposed to 548 
DMBA as described above.  549 
550 
BM chimeras  551 
WT, Tcrd-/- and IL4-/- mice were sub-lethally irradiated (750 rad) and immediately 552 
reconstituted with 5x106 donor BM cells by intravenous injection. Mice were left for 8 weeks 553 
to fully reconstitute the haematopoietic cells, and then exposed to DMBA on the skin as 554 
described. Chimerism was assessed by FACS analysis of peripheral lymph nodes and skin 555 
tissue at the end of the experiments. 556 
557 
qRT-PCR and primer sequences558 
RNA was extracted from ammonium-fixed epidermis, or tumor tissue, preserved in RNA-559 
later, using an RNEasy Mini kit (Qiagen). RNA was dissolved in nuclease-free water, and 560 
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yield and purity were determined. Complementary DNA (cDNA) was synthesised from RNA 561 
with an iScript cDNA synthesis kit (Bio-Rad) as per the manufacturer’s instructions. cDNA 562 
was diluted in nuclease-free double-deionized water for qRT–PCR. All primers were single-563 
stranded DNA oligonucleotides (Sigma) that were intron-spanning as verified by NCBI 564 
Primer-Blast tool. Real-time PCR product was detected with SYBR Green (Life) measured 565 
continuously with a ViiA 7 Real-Time PCR system (Applied Biosystems, CA, USA). Ct 566 
values for genes of interest were normalized against Ct values of the housekeeping gene 567 
Cyclophilin (Cyc) using the 2-ΔCt method. The following primers were used: IgE:  F (5’-568 
CAAGTCAGCCAAGAACTTCAC-3’), R (5’-GACAGGTCGAACTAGGATAGTC-3’), 569 
IgG1: F (5’-TTGCATATGTACAGTCCCAG-3’), R (5’-GTCAGAGTAATGGTGAGCAC-570 
3’), IgM: F (5’-AAGACTGGAATAACAGGAAGGA-3’), R (5’-571 
GTTTGTGCACCTCATTGGG-3’), Rae1: F (5’-TGGACACTCACAAGACCAATG-3’), R 572 
(5’-CCCAGGTGGCACTAGGAGT-3’), IL-4: F (5’-CATCGGCATTTTGAACGAG-3’), R 573 
(5’-CGAGCTCACTCTCTGTGGTG-3’), IL-6: F (5’-TGATGGATGCTACCAAACTGG-574 
3’), R (5’-TTCATGTACTCCAGGTAGCTATGG-3’), IL-33: F (5’-575 
CACATTGAGCATCCAAGGAA-3’), R (5’-AACAGATTGGTCATTGTATGTACTCAG-576 
3’), Cyc: F (5’-CAAATGCTGGACCAAACACAA-3’), R (5’-577 
CCATCCAGCCATTCAGTCTTG-3’).  578 
579 
Immunoglobulin sequencing and analysis 580 
Mice were treated twice with DMBA or TPA to the dorsal side of the ear skin, 3 days apart. 581 
One week after the last exposure, draining-LNs were collected and germinal center B cells 582 
(B220+CD95+GL7+) and plasma cells (FSChiCD95hiCD138+) cell sorted on a BD FACS Aria 583 
III (BD Biosciences, NJ, USA). RNA was extracted using RNEasy Micro kits (Qiagen) and 584 
reverse transcriped using SuperScript™ III Reverse Transcriptase (ThermoFisher). 585 
Sequences were amplified using Phusion High-Fidelity DNA Polymerase (NewEngland 586 
Biolabs) to ensure accuracy and robust performance for large PCR products. PCR with a 587 
primer in the constant Cε region 5’-CTAGGGTCATGGAAGCAGTGCC-3’ or Cγ1 region 588 
5’-GGGAAATAGCCCTTGACCAGG-3’ in combination with a promiscuous V region 589 
primer (binding all Vh genes) 5’-GAGGTGCAGCTGCAGGAGTCTGG-3’ was performed. 590 
All primers were labeled at either end with Multiplex Identifiers (MIDs) for multiplexing. 591 
PCR thermal cycling was as follows: 98°C, 30 sec; 30x (98°C, 30 sec; 60°C, 30 sec; 72°C, 35 592 
sec); and 72°C, 10min. Amplicons were purified by gel extraction using QIAquick PCR 593 
purification kit (Qiagen) and deep-sequenced by long-read 454 pyrosequencing on the 594 
Genome Sequencer FLX system (Roche). Raw sequencing data was presented in .FASTA 595 
format and unproductive sequences removed (data cleanup stages as described61).  596 
Analysis was performed as previously described61. In short: sequences were assigned to 597 
individual samples according to their MID. V(D)J gene assignment of individual sequences 598 
were annotated using IMGT/HighV-Quest and the mouse database. Mean values of V(D)J 599 
gene usage were calculated before 3D bubble plots were created using the R package plot3D. 600 
Repertoire diversity was characterized using the Hill diversity index62, 63 and plotted using the 601 
Alakazam package17. Physiochemical properties of the CDRH3 region were calculated using 602 
the R package Peptides. Physiochemical properties included length, isoelectric point (pI), 603 
frequencies of amino acid classes in the CDRH3 region, and Kidera factors. Kidera factors 604 
are a set of 10 independent factors encapsulating information from ~180 different measurable 605 
biophysical characteristics of the 20 amino acids18. Principal component analysis of Kidera 606 
factors was performed using the prcomp function in R using Minkowski distances as 607 
previously described64.  608 
609 
Human tissue 610 
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For FACS analysis, freshly excised SCC tissue and peripheral blood were obtained from 12 611 
patients during surgery at the Dermatology Department, University Hospital Southampton 612 
NHS Foundation Trust. Ethics were provided by the South Central Hampshire B NRES 613 
Committee (reference number 07/H0504/187). All participants recruited to the study 614 
provided informed consent for blood and tissue samples to be used for research purposes. All 615 
tumor tissue used in the study was confirmed SSCs with a diameter > 8mm. Non-lesional 616 
skin was histopathologically normal and > 6mm away from the tumor edge. To obtain single 617 
cell suspension, tumor samples were cut into small pieces and enzymatically digested with 1 618 
mg/ml collagenase I-A (Sigma) and 10 µg/ml DNAse I (Sigma) in RPMI medium at 37°C for 619 
1.5 hours. The resulting suspension was passed through 70µm cell strainers and centrifuged 620 
in Optiprep (Axis-Shield). PBMCs were isolated from venous blood from the SCC patients 621 
by centrifugation with Lymphoprep (Axis-Shield). Single cell suspensions were stained for 622 
FACS against CD45 (2D1) and FcεR1 (MHE-18) (both BioLegend). Cells were gated on 623 
FSC and SSC and dead cells excluded using near IR live/dead stain (Invitrogen).  624 
For immunohistochemistry on human SSC tissue; 5µm tissue sections were cut from 625 
formalin-fixed paraffin-embedded samples and placed onto 3-aminopropyltriethoxysilane 626 
(APES)-coated microscope slides. Sections were deparaffinised in xylene and rehydrated 627 
through graded alcohols. Endogenous peroxidase was inhibited with 0.5% hydrogen 628 
peroxide, prior to antigen retrieval by microwaving in 10 mM citrate buffer, pH 6. 629 
Endogenous avidin and biotin were blocked (Vector Labs), before Dulbecco’s Modified 630 
Eagle’s Medium (Gibco) containing 1% bovine serum albumin (Sigma) and 20% foetal 631 
bovine serum (Gibco) blocking medium was applied. Primary antibody (FcER1 (9E1), 1:20 632 
dilution (Abcam)) was then left on the sections for 16 hours at 4°C before 3 Tris buffered 633 
saline (TBS) washes, followed by application of biotinylated goat anti-mouse (1:400 dilution, 634 
Jackson ImmunoResearch) for 30 minutes. After 3 TBS washes, streptavidin-biotin 635 
complexes (Vector Labs) were applied, before being washed with TBS x 3 and application of 636 
diaminobenzidine (DAKO). After washing with TBS, sections were counterstained with 637 
Mayer’s Haematoxylin (Sigma) and dehydrated through graded alcohols and xylene. Sections 638 
were mounted in DPX mountant (Sigma) and coverslips applied. Slides were imaged at 2x 639 
and 20x magnification using an Olympus Dotslide microscope and analysed using OlyVIA 640 
software. 641 
For SSC tumor gene expression, fixed frozen paraffin embedded skin samples from 56 642 
patients obtained from the University of Dundee, Tayside NHS Trust and Greater Glasgow 643 
and Clyde NHS Trust were analyzed. The study was conducted according to the Declaration 644 
of Helsinki Principles and all patients donating samples to this study provided written, 645 
informed consent in accordance with ethical approval from the East of Scotland Research 646 
Ethics Service (EoSRES) REC 1. SSC tumors were graded by an experienced 647 
dermatopathologist as low risk or high risk based on the Scottish Intercollegiate Guidelines 648 
Network for cutaneous SCC. In addition, peri-lesional skin (histopathologically normal 649 
looking skin > 4 mm away from the tumor edge) and abdominal non-UV exposed skin were 650 
also analyzed. Total RNA was extracted using Qiagen RNeasy extraction kit and directly 651 
hybridized using the NanoString PanCancer and PanCancer Immune expression panel and 652 
analyzed on a nCounter (NanoString).  653 
654 
Statistical evaluation 655 
The statistical significance of difference between experimental groups was determined using 656 
two-tailed Student’s t-test for unpaired data, Wilcoxon test for paired samples, one-way 657 
ANOVA or linear regression, where appropriate, with results deemed significant at p<0.05. 658 
Stars of significance correlate to: *p<0.05; **P<0.01; ***P<0.001 and ****p<0.0001. 659 
Statistics was performed with GraphPad Prism 6.00 for Mac (GraphPad; La Jolla, CA, USA). 660 
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Data availability 662 
The data supporting the findings of this study are available from the corresponding author 663 
upon request. RNA sequencing data is available from the public repository on the National 664 
Center for Biotechnology Information’s Sequence Read Archive in raw format (BioProject: 665 
PRJNA417372; BioSample accession: SAMN07985450, SAMN07985451, SAMN07985452, 666 
SAMN07985453, SAMN07985454, SAMN07985455). 667 
668 
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Figure legends 921 
922 
Figure 1. Carcinogen-induced EC-damage triggers a rapid local and systemic IgE 923 
response 924 
(a) Shaved back skin of WT FVB mice were exposed to a single topical dose of 200nmol925 
DMBA or vehicle control (acetone). Sera was collected before and 4 days after exposure and 926 
analyzed for IgE (n=10). (b) LC-deficient mice and their non-transgenic littermate controls 927 
(NLC) were exposed to DMBA as in (a) and their sera analyzed for IgE at indicated time-928 
points (n=4-5/group). (c) Shaved back skin of WT FVB mice were topically exposed to 929 
200nmol DMBA once weekly. Sera was analyzed for IgE at indicated time-points 930 
(n=9/group). (a-c) IgE was analyzed by ELISA and data expressed as mean ± SEM. (d) 931 
FACS analysis of IgE-bearing cells in naïve and DMBA-treated skin and in DMBA-induced 932 
skin tumors. Mast cells were defined as CD45hicKit+IgE+ and basophils as CD45locKit-IgE+. 933 
Representative flow plots and enumeration shown (n=5 naïve skin, n=7 DMBA skin, n=6 934 
tumors). (e) Representative image of IgE staining (red) in a DMBA-induced tumor. Nuclei in 935 
blue. (f) Quantitative RT-PCR analysis of mature immunoglobulin transcripts in tumors or 936 
tumor adjacent skin following DMBA carcinogenesis. Data are expressed as mean ± SEM 937 
relative to the control gene cyclophylin (n=7/group). Statistics using two-tailed unpaired 938 
Student’s t-test (a and f), multiple t-tests (b) or one-way ANOVA testing for linear trend of 939 
IgE increase with time (c); **p<0.01, ***p<0.001 and ****p<0.0001. 940 
941 
Figure 2. Topical carcinogen exposure induces local B cell class-switching resulting in a 942 
dominant IgE response 943 
WT FVB mice were exposed topically to DMBA on the dorsal side of the ears twice (3 days 944 
apart) and the draining-LN response analyzed 7 days after last exposure. (a) Total LN cells 945 
were counted and the number of GC B cells defined as B220+CD95+GL7+ LN cells. 946 
Representative flow plots show GC gated B cells and intracellular immunoglobulin staining 947 
to analyse GC B cell class-switching. (b) Representative flow plots of PCs (gated as 948 
FSChiCD95+CD138+ cells) and intracellular immunoglobulin staining to determine isotype 949 
switching (a-b, n=9-11/group). (c) Shaved back skin of FVB WT mice were treated with 950 
DMBA once a week for up to 5 weeks. The axillary LN B cell response was analyzed weekly 951 
by FACS (n=3 per time-point). Statistical analysis by two-tailed Student’s t-test for unpaired 952 
data; *p<0.05, ***p<0.001 and ****p<0.0001. ns = not significant. 953 
954 
Figure 3. EC-damage induced IgE protects against carcinogenesis 955 
(a-b) Shaved backs were treated once weekly with 200nmol DMBA. Animals were scored, 956 
tumors counted and measured once weekly. Data are expressed as tumor latency (time to 957 
appearance of first tumor), tumor incidence (average number of tumors per mouse) and tumor 958 
area (average tumor size per mouse) per (a) BALB/c WT and Igh7-/- mouse (n=14/group) and 959 
(b) BALB/c WT and FceR1a-/- mouse (n=10-11/group). Statistical significance assessed960 
using Log-rank (Mantel-Cox) test comparing tumor latency and linear regression for tumor 961 
incidence and area. (c) Human SSC tissue, peri-lesional skin and matched blood samples 962 
were analyzed by FACS for proportion of FcεRI+ cells among total CD45+ leukocyte 963 
infiltrate (n=12 for SSC and n=10 for peri-lesional skin and blood). Red triangles depict 964 
mean proportion of FcεRI+ cells in the group. Statistical analysis by paired Wilcoxon test; 965 
**p<0.01. (d) Whole human skin and SSC tissue was collected and scored independently for 966 
‘tumor risk’ by an experienced dermatopathologist. Tissue transcripts were analyzed by 967 
NanoString nCounter: non-UV (n=3), peri-lesional (n=6), low risk SSC (n=12), high risk 968 
SSC (n=24) and metastasis (n=11). Log2 RNA counts of FcεRI are shown for individual ‘risk 969 
24
groups’. Statistics using one-way ANOVA and testing for linear trend of expression between 970 
‘risk groups’.   971 
972 
Figure 4. EC damage-induced humoral immunity depends on αβ T cell-derived IL-4 973 
(a) FVB WT, IL4-/- and Tcrb-/- mice were exposed topically to DMBA on the dorsal side of974 
the ears twice (3 days apart) and the draining-LN response analyzed by FACS 7 days after 975 
the last exposure. Total LN cells were counted, the number of GC B cells 976 
(B220+CD95+GL7+) and PCs (FSChiCD95+CD138+) with additional intracellular IgG1/IgE 977 
staining were enumerated (n=5-9/group). Representative flow plots showing IgG1+ and IgE+ 978 
PC in WT, IL4-/- and Tcrb-/- mice. (b) Tcrb-/- mice were reconstituted with WT CD4+ αβ T 979 
cells or IL4-/- CD4+ αβ T cells 1 day prior to DMBA exposure as described in (a). LNs of the 980 
reconstituted mice were analyzed 7 days later (n=3-4/group). Statistical difference between 981 
experimental groups in (a-b) was determined using two-tailed Student’s t-test for unpaired 982 
data; *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. ns = not significant. (c) The shaved 983 
backs of FVB WT and IL4-/- mice were treated once weekly with 200nmol DMBA 984 
(n=9/group). Animals were scored, tumors counted and measured once weekly. Statistical 985 
significance between groups was assessed using Log-rank (Mantel-Cox) test comparing 986 
tumor latency and linear regression for tumor incidence and area. 987 
988 
Figure 5. Induction of tumor-protective IgE requires γδ TCR+ IEL 989 
(a) FVB WT and Tcrd-/- mice were exposed topically to DMBA on the dorsal side of the ears990 
twice (3 days apart) and the draining LN response analyzed 4 or 7 days after the last 991 
exposure. Total LN cells were counted, the number of GC B cells (B220+CD95+GL7+) and 992 
PCs (FSChiCD95+CD138+) positive for IgG1/IgE staining were enumerated (n=6-13/group). 993 
(b) Mice were bled 4 days after topical DMBA exposure and IgE determined by ELISA994 
(n=10/group). (c-d) Lethally irradiated FVB WT or Tcrd-/- mice were reconstituted with 995 
either WT or Tcrd-/- BM cells. 8 weeks after, mice were exposed to DMBA and analyzed as 996 
in (a) at day 7. (c) Number of γδ T cells in the LN, the Vγ5+ γδ T cells in the epidermis (the 997 
IEL), the Vγ4+ and ‘non-Vγ5+’ dermal γδ T cells and (d) the IgG1+/IgE+ PCs in the skin 998 
draining LNs following DMBA exposure (n=5/group). (e) FVB WT and Vg5Vd1-/- mice were 999 
exposed to DMBA and analysed as in (a). Statistical significance in (a-d) determined using 1000 
one-way ANOVA multiple comparison and (e) two-tailed Student’s t-test for unpaired data; 1001 
*p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. ns = not significant. nd = not detected.1002 
1003 
Figure 6. γδ T cells promote a distinct IgE repertoire in response to carcinogen-induced 1004 
EC-damage 1005 
FVB WT and Tcrd-/- mice were exposed topically to DMBA, skin draining LNs collected and 1006 
B cells FACS sorted into PCs and GC B cells. IgG1 and IgE was PCR amplified and long-1007 
read high-throughput sequencing carried out (n=6/group). (a-b) Average clone size calculated 1008 
as total number of sequences/number of unique sequences (clones). (c) Clonal diversity 1009 
throughout the IgG1 and IgE PC repertoires in WT and Tcrd-/- mice, with the ‘General 1010 
diversity index (qD)’ displayed as a measure of ‘clonal frequencies (q)’17. Each line 1011 
represents the average of 6 mice (p<0.05 for IgE from q<22). (d) PCA of ‘Kidera factors’ 1012 
with each plot showing GC and PC IgG1 and IgE in WT (left) and Tcrd-/- mice (right); dots in 1013 
the clusters represents an individual mouse. (e) 3D plot of VDJ gene family usage in PC WT 1014 
IgE (top, blue bubbles) versus Tcrd-/- (bottom, red bubbles). Plots represent average use 1015 
(n=6). V and D genes used in <1% of the total repertoire were removed prior to analysis for 1016 
clarity. (f-g) IgE PC VD repertoire in WT and Tcrd-/- mice with (f) showing the most 1017 
common V1D2 combination as a % of the total repertoire and (g) % use of other VD 1018 
combinations after V1D2 exclusion (n=6). (h) PCA of ‘Kidera factors’ in WT V3Dx clones 1019 
25
compared to other indicated VD families. (i) CDRH3 length and indicated characteristics and 1020 
(j) % mutations in CDRH3 compared to germline of V3Dx clones compared to other VD1021 
families. Each dot represent an individual WT mouse (n=6). Statistical analysis by two-tailed 1022 
Student’s t-test for unpaired data (a, b, f and g) and one-way ANOVA multiple comparison 1023 
(i-j); *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. 1024 
1025 
Figure 7. IgE induced by EC DNA-damage is autoantigenic and the repertoire differs 1026 
from inflammation-induced IgE 1027 
(a) Sera from DMBA-treated WT or Tcrd-/- mice as well as TPA-treated WT mice were1028 
added to HEp-2 slides (in a 1:25, 1:5 and 1:5 dilution respectively to match IgE titers) and 1029 
IgE autoreactivity (red) assessed by secondary staining with α-IgE Ab. Nuclei were 1030 
visualized with DAPI (blue). Representative examples of the most common patterns are 1031 
shown. (b) Anti-ds-DNA autoreactivity of IgE assessed by ELISA. (c) FACS analysis of 1032 
γH2AX expression in CD45- skin EC, as a measure of ds-DNA breaks, at indicated time-1033 
points after topical DMBA or TPA exposure (n=8). (d-g) Long-read, high-throughput 1034 
sequencing of IgE PC repertoires following topical DMBA or TPA (n=6/group). (d) Showing 1035 
average diversity throughout the repertoire with the ‘General diversity index (qD)’ displayed 1036 
as a measure of ‘clonal frequencies (q)’. Each line represent the average of 6 mice per 1037 
condition (p<0.05 throughout the repertoire). (e) PCA of ‘Kidera factors’ with each dot 1038 
representing an individual mouse. (f) 3D plot of VDJ gene family usage in PC IgE from WT 1039 
mice treated topically with TPA. The plot represent average use (n=6). (g) Use of the 5 most 1040 
common V families as a % of the total repertoire and frequency of the V3Dx clones between 1041 
PC IgE induced by topical DMBA or TPA treatment (n=6). Statistics using one-way 1042 
ANOVA multiple comparison (b and c) or two-tailed Student’s t-test for unpaired data (g); 1043 
*p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001. ns = not significant.1044 
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